Suppr超能文献

膳食类黄酮同系物对人癌细胞系的体外活性。

In vitro activity of dietary flavonol congeners against human cancer cell lines.

机构信息

Division of Pharmacology-Pharmacotechnology, Biomedical Research Foundation, Academy of Athens, Athens, Greece.

出版信息

Eur J Nutr. 2012 Mar;51(2):181-90. doi: 10.1007/s00394-011-0204-5. Epub 2011 May 20.

Abstract

BACKGROUND

Flavonoids have physiological activity and a variety of pharmacological properties, including anticancer activity in vitro, but structure-anticancer activity relationships are unclear.

AIM

The objectives of this work were to investigate the activity of dietary flavonol congeners against cell lines derived from human solid tumours and to examine whether the in vitro activity was associated with specific structural feature(s) of the molecules.

METHODS

Antiproliferative activity of the flavonol congeners was investigated against eight different human cancer cell lines representing different types of human solid tumour, using the sulforhodamine B (SRB) assay in accordance with the instructions published by the NCI. Cell cycle perturbations caused by the congeners were monitored by flow-cytometric analysis of DNA stained with propidium iodide.

RESULTS

Most of the flavonols examined had weak antiproliferative and cytotoxic activity. Of all the flavonol congeners tested peracetylated tiliroside found to be the most powerful, with significant antiproliferative and cytotoxic activity. Most flavonols induced similar cell cycle perturbations, whereas induction of apoptosis was significant only for cells treated with peracetylated tiliroside.

CONCLUSIONS

These findings indicated that the -OH groups of aromatic ring B were not linked to the cytotoxic and antiproliferative activity of the tested flavonols whereas peracetylation of the glycosides resulted in moderate improvement. In contrast, acetylation of tiliroside esterified with coumaric acid at position 5 of the sugar moiety greatly improved the activity of this congener. Overall, the results of this study suggest a critical role of sugar moiety substituents in the anticancer activity of the flavonols.

摘要

背景

类黄酮具有生理活性和多种药理特性,包括体外抗癌活性,但结构-抗癌活性关系尚不清楚。

目的

本研究旨在研究膳食类黄酮醇同系物对源自人类实体瘤的细胞系的活性,并研究体外活性是否与分子的特定结构特征相关。

方法

根据 NCI 公布的说明书,采用磺酰罗丹明 B(SRB)法,研究类黄酮醇同系物对 8 种不同的人类癌细胞系(代表不同类型的人类实体瘤)的增殖抑制活性。通过碘化丙啶染色的 DNA 流式细胞术分析监测同系物引起的细胞周期改变。

结果

大多数类黄酮醇的增殖抑制和细胞毒性活性较弱。在所测试的所有类黄酮醇同系物中,乙酰化 tiliroside 是最有效的,具有显著的增殖抑制和细胞毒性活性。大多数类黄酮醇引起相似的细胞周期改变,而只有用乙酰化 tiliroside 处理的细胞才会诱导凋亡。

结论

这些发现表明,芳香环 B 的-OH 基团与所测试的类黄酮醇的细胞毒性和增殖抑制活性无关,而糖苷的乙酰化导致适度改善。相比之下,在糖部分 5 位与香豆酸酯化的 tiliroside 的乙酰化大大提高了该同系物的活性。总体而言,这项研究的结果表明糖部分取代基在类黄酮醇的抗癌活性中起着关键作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验